255 related articles for article (PubMed ID: 26915031)
1. In Epstein-Barr virus-associated gastric carcinoma a high density of CD66b-positive tumor-associated neutrophils is associated with intestinal-type histology and low frequency of lymph node metastasis.
Abe H; Morikawa T; Saito R; Yamashita H; Seto Y; Fukayama M
Virchows Arch; 2016 May; 468(5):539-48. PubMed ID: 26915031
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in Epstein-Barr virus-associated stage I-III gastric carcinoma: implications for a unique type of carcinogenesis.
Huang SC; Ng KF; Chen KH; Hsu JT; Liu KH; Yeh TS; Chen TC
Oncol Rep; 2014 Aug; 32(2):530-8. PubMed ID: 24899228
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.
Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H
Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601
[TBL] [Abstract][Full Text] [Related]
5. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
[TBL] [Abstract][Full Text] [Related]
6. CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8
Abe H; Saito R; Ichimura T; Iwasaki A; Yamazawa S; Shinozaki-Ushiku A; Morikawa T; Ushiku T; Yamashita H; Seto Y; Fukayama M
Virchows Arch; 2018 Apr; 472(4):643-651. PubMed ID: 29536167
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus Positive Gastric Cancer: A Distinct Subtype Candidate for Immunotherapy.
Pereira MA; Batista DAM; Ramos MFKP; Cardili L; Ribeiro RRE; Dias AR; Zilberstein B; Ribeiro U; Cecconello I; Alves VAF; Mello ES
J Surg Res; 2021 May; 261():130-138. PubMed ID: 33429221
[TBL] [Abstract][Full Text] [Related]
8. Low density of CD204-positive M2-type tumor-associated macrophages in Epstein-Barr virus-associated gastric cancer: a clinicopathologic study with digital image analysis.
Ichimura T; Abe H; Morikawa T; Yamashita H; Ishikawa S; Ushiku T; Seto Y; Fukayama M
Hum Pathol; 2016 Oct; 56():74-80. PubMed ID: 27342912
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus.
Chong JM; Fukayama M; Hayashi Y; Funata N; Takizawa T; Koike M; Muraoka M; Kikuchi-Yanoshita R; Miyaki M; Mizuno S
Int J Cancer; 1997 Aug; 74(4):450-4. PubMed ID: 9291438
[TBL] [Abstract][Full Text] [Related]
10. A positive correlation between neutrophils in regional lymph nodes and progression of gastric cancer.
Tokumoto M; Tanaka H; Ohira M; Go Y; Okita Y; Sakurai K; Toyokawa T; Kubo N; Muguruma K; Maeda K; Sawada T; Hirakawa K
Anticancer Res; 2014 Dec; 34(12):7129-36. PubMed ID: 25503140
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
[TBL] [Abstract][Full Text] [Related]
12. Neutrophils in primary gastric tumors are correlated with neutrophil infiltration in tumor-draining lymph nodes and the systemic inflammatory response.
Hiramatsu S; Tanaka H; Nishimura J; Sakimura C; Tamura T; Toyokawa T; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Immunol; 2018 Apr; 19(1):13. PubMed ID: 29661142
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy.
Osumi H; Kawachi H; Yoshio T; Ida S; Yamamoto N; Horiuchi Y; Ishiyama A; Hirasawa T; Tsuchida T; Hiki N; Takeuchi K; Fujisaki J
J Gastroenterol; 2019 Sep; 54(9):774-783. PubMed ID: 30826866
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma.
Chen JN; Jiang Y; Li HG; Ding YG; Fan XJ; Xiao L; Han J; Du H; Shao CK
Virus Res; 2011 Sep; 160(1-2):191-9. PubMed ID: 21723347
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.
Sudo M; Chong JM; Sakuma K; Ushiku T; Uozaki H; Nagai H; Funata N; Matsumoto Y; Fukayama M
Int J Cancer; 2004 Mar; 109(2):194-9. PubMed ID: 14750169
[TBL] [Abstract][Full Text] [Related]
16. Accumulation Mechanisms of CD4(+)CD25(+)FOXP3(+) Regulatory T Cells in EBV-associated Gastric Carcinoma.
Zhang NN; Chen JN; Xiao L; Tang F; Zhang ZG; Zhang YW; Feng ZY; Jiang Y; Shao CK
Sci Rep; 2015 Dec; 5():18057. PubMed ID: 26673957
[TBL] [Abstract][Full Text] [Related]
17. Expression of CCL21 by EBV-associated gastric carcinoma cells protects CD8
Tang F; Chen JN; Zhang NN; Gong LP; Jiang Y; Feng ZY; Xiao L; Li HG; Du H; Wu B; Shao CK
Pathology; 2018 Oct; 50(6):613-621. PubMed ID: 30149990
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of HER2 and downstream proteins in prediction of advanced tumor phenotypes and overall survival of patients with Epstein-Barr virus-positive vs. negative gastric cancers.
Zhang YW; He D; Tan C; Dong M; Zhou L; Shao CK
Pathol Res Pract; 2019 Nov; 215(11):152675. PubMed ID: 31594682
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification for lymph node metastasis using Epstein-Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study.
Osumi H; Kawachi H; Murai K; Kusafuka K; Inoue S; Kitamura M; Yoshio T; Kakusima N; Ishihara R; Ono H; Yamamoto N; Sugino T; Nakatsuka S; Ida S; Nunobe S; Bando E; Omori T; Takeuchi K; Fujisaki J
Gastric Cancer; 2019 Nov; 22(6):1176-1182. PubMed ID: 31062195
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus positivity among surgically resected intramucosal gastric cancer.
Murai K; Kakushima N; Sugino T; Yoshida M; Kawata N; Tanaka M; Takizawa K; Muramatu K; Kusafuka K; Bando E; Ono H
Dig Endosc; 2018 Sep; 30(5):667-671. PubMed ID: 29729036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
